{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":19,"description":"Experimental: Patients will receive a single IV injection of 124I-AT-01 radiotracer and PET/CT imaging\n\nIn this repeat imaging study, patients previously enrolled in the AMY1001 study, in whom positive PET/CT imaging findings were observed will undergo repeat imaging to assess changes in radiotracer uptake in the liver, spleen, heart and kidneys.","id":"EG000","otherNumAffected":1,"otherNumAtRisk":19,"seriousNumAffected":0,"seriousNumAtRisk":19,"title":"All Participants"}],"frequencyThreshold":"0","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","notes":"Severity Mild - Only one treatment-emergent adverse event was reported, worsening of arthralgia, and was ascribed to the Musculoskeletal and connective tissue disorders.","organSystem":"Musculoskeletal and connective tissue disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":19}],"term":"Arthralgia"}],"timeFrame":"From enrollment to the end of the study is 8 days"}